The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of VYVANSE 30 mg capsules. The contract has a potential value of $1,563.77 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the contract was awarded without any set-aside designation. In addition to this specific delivery order, Amerisourcebergen Drug Corp...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $2,885.78 firm fixed price delivery order contract to provide VYVANSE 30 MG CAPSULE 100S. The contract has a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and serves as a supplier of pharmaceutical products and medical supplies to various U.S. government agencies, primarily the Department of Defense. This...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The $1,667.38 contract is to provide 4564222091 VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product, to the agency. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,578,946 units of VYVANSE 30 MG CAPSULES 100S. The $1,789.44 contract has a completion date of February 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 from DLA for the delivery of pharmaceutical products and medical...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,349.07 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VYVANSE 30 MG CAPSULE 100S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,724.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564205036 VYVANSE 40 MG CAPSULE 100S. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00, which serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,692,509 units of VYVANSE 30 mg capsules. The contract has a completion date of February 20, 2024 and a potential value of $1,357.00. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order and does not have any major subcontractors noted. The contract does not have a...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,868.10 contract is for the supply of VYVANSE 70 MG CAPSULE 100S, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a completion date of February 7, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,471,651 units of the prescription drug VYVANSE 30 MG CAPSULE. The order has a total potential value of $2,373.57 and a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not designated as a set-aside contract. This delivery order is part of a larger indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 100 units of the prescription medication VYVANSE 50 MG CAPSULE. The $5,413.84 contract has a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which does not have a set-aside designation. Amerisourcebergen Drug Corp also holds an Indefinite Delivery Contract (IDC)...